Liquidia
Trade Liquidia 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LQDA
Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.
LQDA Key Statistics
Stock Snapshot
As of today, Liquidia(LQDA) shares are valued at $25.78. The company's market cap stands at 2.31B, with a P/E ratio of 18.99.
As of 2026-10-07, Liquidia(LQDA) stock has fluctuated between $24.59 and $26.99. The current price stands at $25.78, placing the stock +4.8% above today's low and -4.5% off the high.
The Liquidia(LQDA)'s current trading volume is 4.14M, compared to an average daily volume of 7.15M.
During the past year, Liquidia(LQDA) stock moved between $21.94 at its lowest and $93.61 at its peak.
During the past year, Liquidia(LQDA) stock moved between $21.94 at its lowest and $93.61 at its peak.
LQDA News
Liquidia reported that a Delaware federal court previously ruled key claims of United Therapeutics’ ‘327 patent valid and infringed by YUTREPIA, while finding o...
Liquidia Technologies (LQDA) announced an update on their ongoing clinical study. Liquidia Technologies, Inc. is running an open-label Phase 4 study called “An...
H.C. Wainwright lowered the firm’s price target on Liquidia (LQDA) to $58 from $130 and keeps a Buy rating on the shares. The court ruling provides near-term un...
Analyst ratings
56%
of 9 ratingsMore LQDA News
Wells Fargo downgraded Liquidia (LQDA) to Equal Weight from Overweight with a price target of $30, down from $108. The judge’s ruling adds uncertainty to L606,...
A single court ruling sent one pulmonary hypertension drugmaker soaring and left its rival fighting for survival, but the legal battle over Yutrepia's future is...
Raymond James downgraded Liquidia to Outperform from Strong Buy with a price target of $53, down from $106. Liquidia’s (LQDA) Delaware court loss on United Ther...
An announcement from Liquidia Technologies ( (LQDA) ) is now available. On September 30, 2026, Liquidia reported that the U.S. District Court for the District...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.